March 29, 2024
What You Need to Know Today:
Apple shareholders looking at an even more volatile six months
Apple is likely to take its shareholders on an even wilder ride in the next six months than they’ve been on since the December all-time high at $199.62. The end result, I think is likely to be a renewed rally beginning in the fall–if you can either hold on through the volatility until then or see your way clear to timing when to buy and sell.
Apple shareholders looking at an even more volatile six months
Apple is likely to take its shareholders on an even wilder ride in the next six months than they’ve been on since the December all-time high at $199.62. The end result, I think is likely to be a renewed rally beginning in the fall–if you can either hold on through the volatility until then or see your way clear to timing when to buy and sell.
Special Report A New World for Dividend Investors Pick #4 Equinor
Equinor (EQNR) is Pick #4 in my Special Report A New World for Dividend Investors. I posted this pick in my long Special Report post. But I wanted to flag it here as well so no one wouldl miss the pick. Dividend Pick #4: Equinor (EQNR)
Special Report A New World for Dividend Investors Pick #3 Nike
Bookkeeping. I made Nike Pick No. 3 in my Special Report A New World for Dividend Investors. You can find the pick and write up i nmy long Special Report post. But I wanted to flag the pick here so no one would miss it. Dividend Pick #3: Nike (NKE)
Counter-counter-attack from Viking Therapeutics in the GLP-1 diabetes/weight loss drug war
First, it was Viking Therapeutics (VKTX) on the attack with trial results that shows its GLP-1 dibetes/weight loss drug out performing current leader of the pack drugs fro Novo Nordisk (NVO) and Eli Lilly (LLY). On the news Viking soared.
Then Novo Nordisk struct back with data of its own showing progress on an oral formulation of its rugs. (All existing GLP-1 drugs are delivered by injection.) That cratered Viking Shares. Now, March 26, Viking has released new Phase 1 trial data from a multiple ascending dose study of the oral version of VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
Please Watch My New YouTube Video: Hot Button Moves NOW Buy CMG
Today’s Hot Button Moves NOW video is Buy Chipotle Mexican Grill (CMG). Chipotle announced it will be spitting 50 to 1. With the stock , currently trading at $2800 the split will bring in a new group of investors. The stock popped about 3.5% the day following the announcement and continued to go up in the following days. It’s contrary to modern capital market theory that a stock announcing a split should go up, but it does need happen. Chipotle has a great long term story. It not only survived the COVID pandemic, but the company drove its digital loyalty membership up to 36 million people and added digital drive-thru lanes, leading to extraordinary growth. Chipotle had a 38% increase in earnings in 2023 and an 8% increase in comparable store sales. That, along with a 26% operating margin, continues to make Chipotle one o the most compelling consumer stocks to own,. I think owning this before the split, which will likely be approved in June, will get you appreciation from the pop on the split, as well as long term gains from this well-run company. Tomorrow I’ll be adding these shares to my lot-term 50 Stocks Portfolio.
Special Report: It’s a new world for dividend income investors: 3 trends (all now posted here) and 10 picks (first 4 picks now posted PFE, BEPC, NKE, and EQNR)
Let’s say you’re a dividend income investor. You need cash income in retirement. Or you want your portfolio to generate cash now so you can invest in new opportunities. Or you just want the extra safety and lower risk that owning a stock with a substantial dividend can bring. Whatever your reasons–and I can think of a lot more–this is a particularly challenging financial market for dividend income investors.But I do think there are strategies dividend income investors can successfully pursue even in this challenging market. In the rest of this Special Report I’m going to explain the three ways I think you should be thinking about dividend income investing in this market. And then I’m going to give you 10 dividend stocks that I think are especially well-suited to producing income (and price appreciation, which is always nice even if you’re an income investor) in this market environment. First pick just posted–Pfizer
Live Market Report (20 minute delay)
Apple shareholders looking at an even more volatile six months
Apple is likely to take its shareholders on an even wilder ride in the next six months than they’ve been on since the December all-time high at $199.62. The end result, I think is likely to be a renewed rally beginning in the fall–if you can either hold on through the volatility until then or see your way clear to timing when to buy and sell.
Special Report A New World for Dividend Investors Pick #4 Equinor
Equinor (EQNR) is Pick #4 in my Special Report A New World for Dividend Investors. I posted this pick in my long Special Report post. But I wanted to flag it here as well so no one wouldl miss the pick. Dividend Pick #4: Equinor (EQNR)
Special Report A New World for Dividend Investors Pick #3 Nike
Bookkeeping. I made Nike Pick No. 3 in my Special Report A New World for Dividend Investors. You can find the pick and write up i nmy long Special Report post. But I wanted to flag the pick here so no one would miss it. Dividend Pick #3: Nike (NKE)
Counter-counter-attack from Viking Therapeutics in the GLP-1 diabetes/weight loss drug war
First, it was Viking Therapeutics (VKTX) on the attack with trial results that shows its GLP-1 dibetes/weight loss drug out performing current leader of the pack drugs fro Novo Nordisk (NVO) and Eli Lilly (LLY). On the news Viking soared.
Then Novo Nordisk struct back with data of its own showing progress on an oral formulation of its rugs. (All existing GLP-1 drugs are delivered by injection.) That cratered Viking Shares. Now, March 26, Viking has released new Phase 1 trial data from a multiple ascending dose study of the oral version of VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
Please Watch My New YouTube Video: Hot Button Moves NOW Buy CMG
Today’s Hot Button Moves NOW video is Buy Chipotle Mexican Grill (CMG). Chipotle announced it will be spitting 50 to 1. With the stock , currently trading at $2800 the split will bring in a new group of investors. The stock popped about 3.5% the day following the announcement and continued to go up in the following days. It’s contrary to modern capital market theory that a stock announcing a split should go up, but it does need happen. Chipotle has a great long term story. It not only survived the COVID pandemic, but the company drove its digital loyalty membership up to 36 million people and added digital drive-thru lanes, leading to extraordinary growth. Chipotle had a 38% increase in earnings in 2023 and an 8% increase in comparable store sales. That, along with a 26% operating margin, continues to make Chipotle one o the most compelling consumer stocks to own,. I think owning this before the split, which will likely be approved in June, will get you appreciation from the pop on the split, as well as long term gains from this well-run company. Tomorrow I’ll be adding these shares to my lot-term 50 Stocks Portfolio.
Special Report: A New World for Dividends Pick #2 BEPC
Bookkeeping. I added this pick to my long Special Report post. I just want to make sure no one missed it. Dividend pick No.2: Brookfield Renewable Corp. (BEPC)
Special Report: New World for Dividends Pick #1 Pfizer
Bookkeeping. I added Pfizer as the first of 10 picks in my Special Report A New World for Dividends. You can find this write up on that long Special Reports post. But I want to make no one misses that pick and update.
Please Watch My New YouTube Video: Quick Pick Digital Realty Trust
Today’s Quick Pick is Digital Realty Trust (DLR). This dividend stock, currently pays at 3.46% (previously a bit higher) but the stock has done well on price appreciation too. This is a different way to play the AI boom–by investing in the data center realty space. Data centers are the hottest part of the real estate market at the moment and AI data center capacity is likely to double in the next 6-10 years. Digital Realty has about 300 data centers worldwide with 40 million square feet of rentable space. They recently made a deal with Brookfield in order to raise more capital to build out more facilities and expand their business. The stock is up only about 5.6% year to date which isn’t great if you’re looking at the AI boom. It is up 43% over the last year but recent guidance from the company disappointed investors. The “meh” stock performance recently marks a good time to get in on a stock that has good dividends and a potential for capital appreciation when growth picks up again. The stock has been a member of my Dividend Portfolio since March 16, 2019. The shares are up 161% since then as of March 25.
Saturday Night Quarterback says, For the week ahead expect…
The week will bring lots of important news on inflation and on the auto sectors and from Adobe on developments in AI. With some strange wrinkles in timing due to the short Good Friday schedule.
Please Watch My New YouTube Video: What Powell Said and What the Market Heard
Today’s video is What Powell Said, and What the Market Heard. Jerome Powell, Chair of the Federal Reserve, tried to walk a fine line during Wednesday’s press conference. He said that while inflation is sticky; he’s still confident in a soft landing at 2.0% and that they will cut rates once they confirm that a 2.0% rate is achievable. What the market heard was “we can tolerate higher inflation for longer while still cutting rates, ” and this is backed up by the Fed’s Dot Plot economic projections . The Dot Plot lays out 2-3 cuts in 2024 even though core PCE inflation rates are expected to be at 2.6% at the end of the year–not the target of 2.0%. That 2.0% target will now not likely be reached until the end of 2026, the Fed’s own economic projections say. The market reacted to the news that they heard as “the Fed is no longer insisting on the 2.0% target and will be cutting rates this year,” by hitting its 20th all-time high for 2024. The market heard happy days are here again, and rallied.
Hey, Federal Reserve! What about the real world like, oh, wages?
You know the saying, When all you have is a hammer, every problem looks like a nail? How about this data world version, When you don’t track the data, you can’t see the problem? I was drawn to paraphrase the classic hammer/nail adage by the release of the Federal Reserve’s most recent economic projections, the Dot Plot, on Wednesday, March 20 when I thought about the economic data the Fed didn’t include in its projections.
Initial claims for unemployment drop for the week
Initial claims for state unemployment benefits dropped 2,000 to a seasonally adjusted 210,000 for the week ended March 16, the Labor Department reported today, March 21. Economists polled by Reuters had forecast 215,000 claims in the latest week. Continuing claims for unemployment increased 4,000 to 1.807 million during the week ending March 9, the report on Thursday showed. The Federal Reserve has been looking for signs that the labor market is weakening before raising interest rates. So far the evidence is inconclusive.
No surprise! on interest rates from the Federal Reserve today
The Federal Reserve unanimously voted to leave the benchmark Fed Funds rate in a range of 5.25% to 5.5%, the highest since 2001, for a fifth straight meeting. They left their projections in the quarterly Dot Plot for the Fed Funds rate by the end of 2024 at 4.6%. That was the same projection as in the December Dot Plot. And nothing in either the post-meeting press statement or in Fed chair Jerome Powell’s press remarks changed the timing on when the Fed will make its first interest rate cut.
Please Watch My New YouTube Video: Hot Button Moves NOW Buy Madrigal Pharmaceuticals
Today’s Hot Button Moves NOW video is Buy Madrigal Pharmaceuticals (MDGL). This biotech company just received U.S. Food and Drug Administration approval for the first drug available for treating MASH (formerly known as NASH). MASH is a liver disease where fat builds up and compromise liver function. It’s measured in stages (1-4) and at stage 4, you need a liver transplant. Companies have long worked toward a treatment for the disease but have failed in trials or in getting FDA approval. The major achievements for Madrigal are efficacy in stopping the disease from progressing to the next stage and a clean label and no “black box warnings.” Additionally, this drug does not require a liver biopsy before a doctor can prescribe it and will be available after a much less invasive test. The market for this drug is forecast at $5 billion a year market. Madrigal will be able to start selling this drug in April. The Medical Technology Stock Letter, my preferred source on all things biotech, suggests buying MDGL below $300 with a target price of $400. I’m adding Madrigal Pharmaceuticals to my 12-18 month Jubak’s Picks Portfolio.
Chipotle to split 50-1 in June
Chipotle Mexican Grill (CMG) said on Tuesday, March 19, that its board of directors had approved a 50-for-one split of its common stock.
Special Report: It’s a new world for dividend income investors: 3 trends (all now posted here) and 10 picks (first 4 picks now posted PFE, BEPC, NKE, and EQNR)
Let’s say you’re a dividend income investor. You need cash income in retirement. Or you want your portfolio to generate cash now so you can invest in new opportunities. Or you just want the extra safety and lower risk that owning a stock with a substantial dividend can bring. Whatever your reasons–and I can think of a lot more–this is a particularly challenging financial market for dividend income investors.But I do think there are strategies dividend income investors can successfully pursue even in this challenging market. In the rest of this Special Report I’m going to explain the three ways I think you should be thinking about dividend income investing in this market. And then I’m going to give you 10 dividend stocks that I think are especially well-suited to producing income (and price appreciation, which is always nice even if you’re an income investor) in this market environment. First pick just posted–Pfizer
Please Watch My New YouTube Video: Quick Pick Lithium Americas
Today’s Quick Pick is Lithium Americas (LAC). Lithium Americas is an American lithium producer, with a big deposit in Thacker Pass that has been going through litigation and delays while struggling to get enough financing with lithium prices down. We’ll likely see a bottom of lithium prices in the second half of 2024 or early 2025, so this is a good time to be getting in near the bottom. Lithium Americas signed a contract with General Motors agreeing that GM would take all the lithium they can produce, the question is, Can they produce it? Recently, the Department of Energy announced they’ll be lending Lithium Americas $2.3 billion to move forward with their processing facility. At the moment, China controls nearly all of the processing facilities for lithium globally and this investment will allow for domestic processing. This loan will cover all their capital costs and enable them to start production. The stock is moving upward, with shares around $6.50 per share. The recent rally has brought the stock back up to the price from December 2023, and the Wall Street consensus is that the stock may hit $11.50 in a year. While that prediction may be a bit ambitious, I think it’s likely we’ll see it reach $9-10, up about a third once they start to actually produce lithium in conjunction with lithium prices going up.
Please Watch My New YouTube Video: Interest Rate Cut Transition Going Well
Today’s video is Interest Rate Cut Transition Going Well. Well, so far. Until Wednesday, anyway. Last week we had another batch of bad inflation news: the inflation rate has stopped its decline, and even crept upward a bit. However, the market hasn’t panicked. Wall Street has moved the goalpost for a rate cut from the upcoming March 20 meeting to the June or July meeting. Last week’s bad news dropped the odds for a rate cut by the June 12 meeting on the CME Fedwatch Tool to 63.1%, down slightly from the previous day. The odds of no move on the June 12 meeting are on their way to 40%. Investors have set their sights on July. This will likely continue to push the market sideways until April when we get a bit of earnings excitement, again, around AI. Consolidation after the rally early in the year isn’t a bad thing for the market, and as long as no one panics, I think we’ll see a relatively smooth transition to the eventual interest rate cuts.
Credit card delinquency rates keep rising
About 8.5% of credit card balances and 7.7% of auto loans moved into delinquency in the fourth quarter of 2023, the Federal Reserve Bank of New York reported last week. “Credit card and auto loan transitions into delinquency are still rising above pre-pandemic levels,” said Wilbert van der Klaauw, economic research advisor at the New York Fed. “This signals increased financial stress, especially among younger and lower-income households.” Total household debt increased by $212 billion last quarter to $17.5 trillion
My 10 Penny Stock Homeruns Pick #9: Lithium Americas (LAC)
This week Lithium Americas’ efforts to develop a huge new lithium mine at Thacker Pass in Nevada got a big a boost when the Department of Energy announced a $2.26 billion loan to the company to build processing facilities at the project. This gives the company the financing it needs to take the mine to first phase production scheduled for 2027. Plans call for producing 40,000 tons of battery grade lithium carbonate per year when the first phase of production begins.